Docket Number:12A-1050526
Inventor:Patrick CH Hsieh, Chen-Yun Chen, Yu-Che Cheng
IP Status:TW I654996
Abstract:
TGFBR3 is a membrane protein mediating cell death signaling. For example, TGFBR3 was increased in injured tissue after myocardial infarction. Since the extracellular domain of TGFBR3 can be cleaved and released into bloodstream, it can be used to evaluate indirectly the degree of tissue damage. Besides, targeting of TGFBR3 may be used to rescue cell death after injury.
Fields of Application:
- Detection of circulating TGFBR3 could be used to diagnosis and prognosis of cell damage after myocardial infarction.
- Targeting TGFBR3 could be used to rescue cell death.
Advantages when compared to the existing technologies:
- Comparing to current biomarker cardiac troponin T and CK-MB, which are elevated only in the acute phase of diseases. In large animal study, TGFBR3 could be detected in plasma one week after myocardial infarction.
- The concentration of plasma TGFBR3 is higher than cardiac troponin T and CK-MB, which reduces possibility of false positive and false negative.
- TGFBR3 could serve as a target protein in the treatment of myocardial infarction.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
